These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23633451)

  • 1. Interpreting cancer biology: refining our therapeutic algorithm in breast cancer.
    Hortobágyi G; Conte P
    Oncologist; 2013; 18(4):e8-10. PubMed ID: 23633451
    [No Abstract]   [Full Text] [Related]  

  • 2. The Dawning of Translational Breast Cancer: From Bench to Bedside.
    Chen X; Fan S; Song E
    Adv Exp Med Biol; 2017; 1026():1-25. PubMed ID: 29282677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational Genomics: Practical Applications of the Genomic Revolution in Breast Cancer.
    Yates LR; Desmedt C
    Clin Cancer Res; 2017 Jun; 23(11):2630-2639. PubMed ID: 28572257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Breast cancer: the time of genetic testing and targeted treatments].
    Nau JY
    Rev Med Suisse; 2014 Feb; 10(418):460-1. PubMed ID: 24640285
    [No Abstract]   [Full Text] [Related]  

  • 5. Refining breast cancer risk assessment with molecular markers: the next step?
    Ellis MJ; Hayes DF
    J Natl Cancer Inst; 1999 Dec; 91(24):2067-8. PubMed ID: 10601370
    [No Abstract]   [Full Text] [Related]  

  • 6. Refining Treatment Decisions in Older Patients With Breast Cancer.
    Flaum L; Gradishar WJ
    JAMA Oncol; 2015 May; 1(2):166-7. PubMed ID: 26181016
    [No Abstract]   [Full Text] [Related]  

  • 7. Breast cancer biology and the future of tailored therapies. Introduction.
    Bergh J; Hall P; Östman A; Toftgård R
    J Intern Med; 2013 Aug; 274(2):102-4. PubMed ID: 23844913
    [No Abstract]   [Full Text] [Related]  

  • 8. Biomarkers in Breast Cancer: Where Are We and Where Are We Going?
    Duffy MJ; Walsh S; McDermott EW; Crown J
    Adv Clin Chem; 2015; 71():1-23. PubMed ID: 26411409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-Expression-Based Predictors for Breast Cancer.
    Gupta A; Mutebi M; Bardia A
    Ann Surg Oncol; 2015 Oct; 22(11):3418-32. PubMed ID: 26215189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumoral heterogeneity of breast cancer.
    Roulot A; Héquet D; Guinebretière JM; Vincent-Salomon A; Lerebours F; Dubot C; Rouzier R
    Ann Biol Clin (Paris); 2016 Dec; 74(6):653-660. PubMed ID: 27848916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into long non-coding RNAs in breast cancer: Biological functions and therapeutic prospects.
    Wang MQ; Zhu WJ; Gao P
    Exp Mol Pathol; 2021 Jun; 120():104640. PubMed ID: 33878314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.
    Takahashi Y; Iwamoto T; Suzuki Y; Kajiwara Y; Hatono M; Tsukioki T; Kawada K; Kochi M; Ikeda H; Shien T; Taira N; Matsuoka J; Doihara H; Toyooka S
    Clin Breast Cancer; 2020 Apr; 20(2):117-124.e4. PubMed ID: 31570267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential therapeutic target for triple-negative breast cancer.
    Gilbert JA
    Lancet Oncol; 2012 Aug; 13(8):e330. PubMed ID: 23024992
    [No Abstract]   [Full Text] [Related]  

  • 14. Genomic Profiling in Node-Positive ER-Positive Early Breast Cancer: Can Tumor Biology Guide Locoregional Therapy?
    Garrido-Castro AC; Winer EP
    J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376163
    [No Abstract]   [Full Text] [Related]  

  • 15. A view on the landscape of breast cancer brain metastases.
    Malani R
    CNS Oncol; 2020 Sep; 9(3):CNS59. PubMed ID: 32990026
    [No Abstract]   [Full Text] [Related]  

  • 16. Current advances in the diagnosis and personalized treatment of breast cancer: lessons from tumor biology.
    Kern R; Correa SC; Scandolara TB; Carla da Silva J; Pires BR; Panis C
    Per Med; 2020 Sep; 17(5):399-420. PubMed ID: 32804054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy.
    Kanchan RK; Siddiqui JA; Mahapatra S; Batra SK; Nasser MW
    Mol Cancer; 2020 Feb; 19(1):29. PubMed ID: 32059676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular markers for breast cancer diagnosis, prognosis and targeted therapy.
    Lang JE; Wecsler JS; Press MF; Tripathy D
    J Surg Oncol; 2015 Jan; 111(1):81-90. PubMed ID: 25091830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor microRNAs: Targeted molecules and signaling pathways in breast cancer.
    Asghari F; Haghnavaz N; Baradaran B; Hemmatzadeh M; Kazemi T
    Biomed Pharmacother; 2016 Jul; 81():305-317. PubMed ID: 27261608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles: An overview of biogenesis, function, and role in breast cancer.
    Zha QB; Yao YF; Ren ZJ; Li XJ; Tang JH
    Tumour Biol; 2017 Feb; 39(2):1010428317691182. PubMed ID: 28231725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.